Pacific Biosciences
PACB
PACB
212 hedge funds and large institutions have $373M invested in Pacific Biosciences in 2025 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 70 increasing their positions, 48 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
4.48% more ownership
Funds ownership: 62% → 66.48% (+4.5%)
3% more funds holding
Funds holding: 206 → 212 (+6)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
212
Holding in Top 10
1
Calls
$7.02M
Puts
$1.74M
Top Buyers
| 1 | +$12.2M | |
| 2 | +$8.53M | |
| 3 | +$7.4M | |
| 4 |
CC
Casdin Capital
New York
|
+$6.73M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.68M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$6.37M | |
| 3 | -$1.71M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$1.67M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$1.67M |
